Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial

被引：0
作者：
Shahin Akhondzadeh
Raofeh Ghayyoumi
Farzin Rezaei
Bahman Salehi
Amir-Hossein Modabbernia
Azad Maroufi
Gholam-Reza Esfandiari
Mehrangiz Naderi
Fariba Ghebleh
Mina Tabrizi
Shams-Ali Rezazadeh
机构：
[1] Tehran University of Medical Sciences,Psychiatric Research Center, Roozbeh Psychiatric Hospital
[2] Kurdistan University of Medical Sciences,Qods Hospital
[3] Arak University of Medical Sciences,Shaheed Hashemi Senejani Hospital
[4] Tehran University of Medical Sciences,Department of Medical Genetics, Faculty of Medicine
[5] Institute of Medicinal Plants (ACECR),undefined
来源：
Psychopharmacology | 2011年 / 213卷
关键词：
Adjunctive therapy; Sildenafil; Negative symptoms; Schizophrenia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：809 / 815
页数：6
相关论文
共 79 条
  • [1] Abbasi SH(2010)The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: a double-blind randomized placebo-controlled trial Schizophr Res 116 101-106
  • [2] Behpournia H(1998)The glutamate hypothesis of schizophrenia J Clin Pharm Ther 23 243-246
  • [3] Ghoreshi A(2001)The 5-HT hypothesis of schizophrenia IDrugs 4 295-300
  • [4] Salehi B(2006)Pharmacotherapy of schizophrenia: the past, present and future Curr Drug Ther 1 1-7
  • [5] Raznahan M(1999)Cyproheptadine in treatment of chronic schizophrenia: a double-blind, placebo-controlled study J Clin Pharm Ther 24 49-42
  • [6] Rezazadeh SA(2006)Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia Schizophr Res 84 405-410
  • [7] Rezaei F(2007)Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial Schizophr Res 90 179-185
  • [8] Akhondzadeh S(2007)Persistent negative symptoms in schizophrenia: an overview Schizophr Bull 33 1013-1022
  • [9] Akhondzadeh S(2007)Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or cul-de-sac? Acta Psychiatr Scand 115 93-100
  • [10] Akhondzadeh S(2004)Schizophrenia: from dopamine to glutamate and back Curr Med Chem 11 267-277
12345678